Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice

PLoS Pathogens

Volumn 11, Issue 6, 2015, Pages

  Zhang, Junjie ^a   Zhu, Lining ^a   Lu, Xiaolu ^a   Feldman, Emily R ^b   Keyes, Lisa R ^b   Wang, Yi ^a   Fan, Hui ^c   Feng, Hao ^c   Xia, Zanxian ^d   Sun, Jiya ^e   Jiang, Taijiao ^e,f,g   Gao, Shou jiang ^a   Tibbetts, Scott A ^b   Feng, Pinghui ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c HUNAN NORMAL UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^f SUZHOU INSTITUTE OF SYSTEMS MEDICINE   (China)

^g INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; GUANINE NUCLEOTIDE BINDING PROTEIN; VIRAL PROTEIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; GAMMAHERPESVIRINAE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; LATENT VIRUS INFECTION; MOUSE; MURINE GAMMA HERPESVIRUS 68; NONHUMAN; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; VIRUS REPLICATION; ANIMAL; DISEASE MODEL; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RHADINOVIRUS; VIROLOGY; VIRUS INFECTION; VIRUS LATENCY;

ANIMALIA; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; MURINAE; MUS; MUS MUSCULUS; RODENTIA;

ANIMALS; DISEASE MODELS, ANIMAL; GTP-BINDING PROTEINS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; RHADINOVIRUS; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 84936777443     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005001     Document Type: Article

References (54)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869. 7997879
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM, (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191. 7700311
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86: 1276–1280. 7632932
4. Nador RG, Cesarman E, Knowles DM, Said JW, (1995) Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med 333: 943.
5. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, et al. (1997) Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71: 715–719. 8985403
6. Kirshner JR, Staskus K, Haase A, Lagunoff M, Ganem D, (1999) Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol 73: 6006–6014. 10364352
7. Ganem D, (2006) KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1: 273–296. 18039116
8. Speck SH, Ganem D, (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8: 100–115. doi: 10.1016/j.chom.2010.06.014 20638646
9. Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, et al. (2009) Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog 5: e1000606. doi: 10.1371/journal.ppat.1000606 19798430
10. Austgen K, Oakes SA, Ganem D, (2012) Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells. J Virol 86: 1877–1882. doi: 10.1128/JVI.06600-11 22130538
11. Dittmer D, Stoddart C, Renne R, Linquist-Stepps V, Moreno ME, et al. (1999) Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med 190: 1857–1868. 10601360
12. Ballon G, Chen K, Perez R, Tam W, Cesarman E, (2011) Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest 121: 1141–1153. doi: 10.1172/JCI44417 21339646
13. Fakhari FD, Jeong JH, Kanan Y, Dittmer DP, (2006) The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Invest 116: 735–742. 16498502
14. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, et al. (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23–36. 12559173
15. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, et al. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445–454. 10662790
16. Holst PJ, Rosenkilde MM, Manfra D, Chen SC, Wiekowski MT, et al. (2001) Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest 108: 1789–1796. 11748262
17. Moore PS, Boshoff C, Weiss RA, Chang Y, (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274: 1739–1744. 8939871
18. Virgin HWt, Latreille P, Wamsley P, Hallsworth K, Weck KE, et al. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71: 5894–5904. 9223479
19. Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY, (2001) Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356: 581–593. 11313013
20. Tarakanova VL, Suarez F, Tibbetts SA, Jacoby MA, Weck KE, et al. (2005) Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol 79: 14668–14679. 16282467
21. Dorsam RT, Gutkind JS, (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79–94. 17251915
22. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E, (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347–350. 9002520
23. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86–89. 9422510
24. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, Gershengorn MC, (1998) Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 188: 405–408. 9670053
25. Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I, (1998) Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102: 1469–1472. 9788958
26. Ho HH, Du D, Gershengorn MC, (1999) The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity. J Biol Chem 274: 31327–31332. 10531332
27. Lee BJ, Koszinowski UH, Sarawar SR, Adler H, (2003) A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J Immunol 170: 243–251. 12496406
28. Cannon M, Philpott NJ, Cesarman E, (2003) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol 77: 57–67. 12477810
29. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS, (2008) An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27: 1844–1852. 17934524
30. Feng H, Dong X, Negaard A, Feng P, (2008) Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity. PLoS Pathog 4: e1000157. doi: 10.1371/journal.ppat.1000157 18802460
31. Zhang J, He S, Wang Y, Brulois K, Lan K, et al. (2015) Herpesviral G protein-coupled receptors activate NFAT to induce tumor formation via inhibiting the SERCA calcium ATPase. PLoS Pathog 11: e1004768. doi: 10.1371/journal.ppat.1004768 25811856
32. Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, et al. (2006) The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10: 133–143. 16904612
33. Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, et al. (2007) In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11: 245–258. 17349582
34. Nealy MS, Coleman CB, Li H, Tibbetts SA (2010) Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells express LANA throughout chronic gammaherpesvirus infection. J Virol.
35. Tibbetts SA, Loh J, Van Berkel V, McClellan JS, Jacoby MA, et al. (2003) Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol 77: 7696–7701. 12805472
36. Collins M, Ling V, Carreno BM, (2005) The B7 family of immune-regulatory ligands. Genome Biol 6: 223. 15960813
37. Ensoli B, Sirianni MC, (1998) Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Crit Rev Oncog 9: 107–124. 9973245
38. Dong X, Feng P, (2011) Murine gamma herpesvirus 68 hijacks MAVS and IKKbeta to abrogate NFkappaB activation and antiviral cytokine production. PLoS Pathog 7: e1002336. doi: 10.1371/journal.ppat.1002336 22110409
39. Feng H, Sun Z, Farzan MR, Feng P, (2010) Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation. J Virol 84: 3351–3361. doi: 10.1128/JVI.01939-09 20106924
40. Sandford G, Choi YB, Nicholas J, (2009) Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication. J Virol 83: 13009–13014. doi: 10.1128/JVI.01399-09 19793819
41. Bottero V, Sharma-Walia N, Kerur N, Paul AG, Sadagopan S, et al. (2009) Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression. Virology 392: 34–51. doi: 10.1016/j.virol.2009.07.002 19640558
42. Tacconi D, Vergori A, Lapini L, Magnolfi A, Carnevali A, et al. (2012) Hepatic Kaposi's sarcoma in a patient affected by AIDS: Correlation between histology and imaging. J Ultrasound 15: 215–219. doi: 10.1016/j.jus.2012.10.004 23730384
43. Sterling RK, Herbener TE, Jacobs GH, Post AB, Carey JT, et al. (1997) Multifocal hepatic lesions in AIDS: an unusual presentation of steatosis. Am J Gastroenterol 92: 1934–1936. 9382073
44. Luburich P, Bru C, Ayuso MC, Azon A, Condom E, (1990) Hepatic Kaposi sarcoma in AIDS: US and CT findings. Radiology 175: 172–174. 2179988
45. Micheletti AR, Macedo AC, Silva GB, Silva AC, Silva-Vergara ML, et al. (2011) Benign and malignant neoplasias in 261 necropsies for HIV-positive patients in the period of 1989 to 2008. Rev Inst Med Trop Sao Paulo 53: 309–314. 22183453
46. Sica A, Larghi P, Mancino A, Rubino L, Porta C, et al. (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18: 349–355. doi: 10.1016/j.semcancer.2008.03.004 18467122
47. Feng P, Scott CW, Cho NH, Nakamura H, Chung YH, et al. (2004) Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol Cell Biol 24: 3938–3948. 15082787
48. Feng P, Everly DN, Jr.Read GS, (2001) mRNA decay during herpesvirus infections: interaction between a putative viral nuclease and a cellular translation factor. J Virol 75: 10272–10280. 11581395
49. Izumiya Y, Kobayashi K, Kim KY, Pochampalli M, Izumiya C, et al. (2013) Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation. PLoS Pathog 9: e1003506. doi: 10.1371/journal.ppat.1003506 23990779
50. Paden CR, Forrest JC, Tibbetts SA, Speck SH, (2012) Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog 8: e1002906. doi: 10.1371/journal.ppat.1002906 22969427
51. He S, Zhao J, Song S, He X, Minassian A, et al. (2015) Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production. Mol Cell 58: 134–146. doi: 10.1016/j.molcel.2015.01.036 25752576
52. Feng P, Park J, Lee BS, Lee SH, Bram RJ, et al. (2002) Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J Virol 76: 11491–11504. 12388711
53. Wang Y, Lu X, Zhu L, Shen Y, Chengedza S, et al. (2013) IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesis. Proc Natl Acad Sci U S A 110: 11139–11144. doi: 10.1073/pnas.1219829110 23771900
54. Smith GA, Enquist LW, (1999) Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J Virol 73: 6405–6414. 10400733